Rooted in science

sourced worldwide

LianBio is a biotechnology company focused on bringing paradigm-shifting medicines to patients.


Scroll to see more



Our Mission

LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries.

Learn More


Our Future

We are focused on building out a pipeline based on disease relevance to our target markets and the ability to impact patients with transformative mechanisms and precision-based therapeutics. We select programs with a strong scientific basis and clinical data and collaborate with world-class partners across a diverse array of therapeutic areas.

See All

Stay up to date

News & Events

May 12, 2022

LianBio Reports First Quarter 2022 Financial Results and Provides Corporate Update


May 9, 2022

LianBio Completes Phase 1 Pharmacokinetic Study of Mavacamten in Healthy Chinese Volunteers


May 5, 2022

LianBio to Participate in the Bank of America Securities 2022 Healthcare Conference


May 3, 2022

LianBio Partner Tarsus Pharmaceuticals Announces Positive Topline Data from Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis

See All

We are here for you

Contact Us

Email us directly:

Office Addresses

Shanghai Office
9th Floor, Kerry Parkside, 1155 Fangdian Road
Unit 901-902
Shanghai, PRC 201204

New Jersey Office
103 Carnegie Center Drive
Suite 309
Princeton, NJ 08540

Beijing Office
Room 115, 3rd Floor, N3 Building, Taigu Li North District
No. 11 Sanlitun Road, Chaoyang District
Beijing, PRC 100027

Guangzhou Office
B20, 41 / F, Tower H, Gaode Land Winter Plaza
12-16 Zhujiang East Road, Tianhe District
Guangzhou, PRC 510623